169673-60-3
169673-60-3
Chemical Structure
CPA 926
- CAS No.: 169673-60-3
- Formula:C17H19NO9
- Molecular Weight:381.33
IUPAC Name: N-((2S,3R,4R,5S,6R)-4,5-dihydroxy-2-((7-hydroxy-2-oxo-2H-chromen-6-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide
InChIKey: OTXAWKXSJDFGID-LMHBHQSJSA-N
SMILES: OC1=C(C=C2C(OC(C=C2)=O)=C1)O[C@H]3[C@@H]([C@H]([C@H](O)[C@@H](CO)O3)O)NC(C)=O
Biological Activity: CPA 926 is a prodrug of Esculetin (HY-N0284) and is orally active. CPA 926 can inhibit the production of MMP in cartilage explants. CPA 926 can be used for the research of inflammation, such as experimental osteoarthritis[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CPA 926 | CPA 926 is a prodrug of Esculetin (HY-N0284) and is orally active. CPA 926 can inhibit the production of MMP in cartilage explants. CPA 926 can be used for the research of inflammation, such as experimental osteoarthritis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Yamada H, et al. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis. J Rheumatol. 1999 Mar;26(3):654-62. [Content Brief]
Keywords
